Carmina, Enrico

Polycystic ovary syndrome

Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2,005

Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 1,976

American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome–part 1

Goodman, N. F., Cobin, R. H., Futterweit, W., Glueck, J. S., Legro, R. S., & Carmina, E. (2015) · Endocrine Practice

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 623

Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women

Carmina, E., & Lobo, R. A. (1999) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 528

Lipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 477

Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism

Carmina, E., Rosato, F., Jannì, A., Rizzo, M., & Longo, R. A. (2006) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersSexual Differentiation and Disorders

Cited by 420

The diagnosis of polycystic ovary syndrome in adolescents

Carmina, E., Oberfield, S. E., & Lobo, R. A. (2010) · American Journal of Obstetrics and Gynecology

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 339

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

Palomba, S., Orio, F., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2005) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersReproductive Biology and Fertility

Cited by 279

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters

Carmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 274

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

Guastella, E., Longo, R. A., & Carmina, E. (2010) · Fertility and Sterility

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 205

21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study

Moran, C., Azziz, R., Carmina, E., Dewailly, D., Fruzzetti, F., Ibañez, L., Knochenhauer, E. S., Marcondes, J. A. M., Mendonca, B. B., Pignatelli, D., et al. (2000) · American Journal of Obstetrics and Gynecology

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 185

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia

Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 174

Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause

Welt, C. K., & Carmina, E. (2013) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersReproductive Biology and Fertility

Cited by 148

Atherogenic Lipoprotein Phenotype and Low-Density Lipoproteins Size and Subclasses in Women with Polycystic Ovary Syndrome

Berneis, K., Rizzo, M., Lazzaroni, V., Fruzzetti, F., & Carmina, E. (2007) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 121

Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin

Chu, M. C., Cosper, P., Orio, F., Carmina, E., & Lobo, R. A. (2006) · American Journal of Obstetrics and Gynecology

Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 113

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome

Palomba, S., Russo, T., Orio, F., Falbo, A., Manguso, F., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2006) · Human Reproduction

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 85

Increased circulating levels of immunoreactive β-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion

Carmina, E., Ditkoff, E. C., Malizia, G., Vijod, A. G., Janni, A., & Lobo, R. A. (1992) · American Journal of Obstetrics and Gynecology

Ovarian function and disordersNeuropeptides and Animal Physiology

Cited by 27